Kathryn E. Giusti
Founder at The Multiple Myeloma Research Foundation, Inc.
Net worth: 47 816 $ as of 2023-10-30
Profile
Kathryn E.
Giusti is the founder of The Multiple Myeloma Research Foundation, Inc. (founded in 1998) where she holds the title of Director.
She was also the founder of the Multiple Myeloma Research Consortium (founded in 2004) where she held the title of Chief Executive Officer.
In addition, she is the founder of the Kraft Precision Medicine Accelerator at Harvard Business School (founded in 2016) where she holds the title of Co-Chairman.
Ms. Giusti's current job(s) include being a Director at EQRx International, Inc. (since 2021) and a Member at FasterCures.
Her former job(s) include being a Director at IQVIA, Inc., Executive Director-Worldwide Arthritis Franchise at G.D.
Searle & Co., Inc. (from 1992 to 1997), Independent Director at EQRx, Inc. (from 2021 to 2023), and Principal at Merck & Co., Inc. (from 1980 to 1983).
Ms. Giusti's education history includes an undergraduate degree from the University of Vermont and an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EQRX, INC.
0.00% | 2023-11-08 | 21,934 ( 0.00% ) | 47 816 $ | 2023-10-30 |
Kathryn E. Giusti active positions
| Companies | Position | Start |
|---|---|---|
The Multiple Myeloma Research Foundation, Inc.
 The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Founder | 1997-12-31 |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Director/Board Member | 2021-09-26 |
| Harvard Business School | Founder | 2015-12-31 |
| FasterCures | Corporate Officer/Principal | - |
Former positions of Kathryn E. Giusti
| Companies | Position | End |
|---|---|---|
| EQRX, INC. | Director/Board Member | 2023-11-08 |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Corporate Officer/Principal | 1997-02-28 |
| MERCK & CO., INC. | Corporate Officer/Principal | 1982-12-31 |
Multiple Myeloma Research Consortium
 Multiple Myeloma Research Consortium Miscellaneous Commercial ServicesCommercial Services Multiple Myeloma Research Foundation, the mission of the MMRF is to accelerate the development of novel and combination treatments for patients with multiple myeloma by promoting and facilitating collaborative research between industry and academia. The MMRC is led by an exceptional Leadership Team, including a full scientific and clinical staff, which is headquartered in Norwalk, Conn | Chief Executive Officer | - |
| IMS HEALTH, INC. | Director/Board Member | - |
Training of Kathryn E. Giusti
| University of Vermont | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| EQRX, INC. | Health Technology |
| Private companies | 6 |
|---|---|
IQVIA, Inc.
 IQVIA, Inc. Data Processing ServicesTechnology Services IQVIA, Inc. provides information technology solutions to the healthcare industry. It offers research and development, enterprise information management, commercial analytics, market analysis, patient consent system, content management, and other related solutions. The company was founded by Bill Frohlich and David Dubow in 1954 and is headquartered in Danbury, CT. | Technology Services |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Commercial Services |
Multiple Myeloma Research Consortium
Multiple Myeloma Research Consortium Miscellaneous Commercial ServicesCommercial Services Multiple Myeloma Research Foundation, the mission of the MMRF is to accelerate the development of novel and combination treatments for patients with multiple myeloma by promoting and facilitating collaborative research between industry and academia. The MMRC is led by an exceptional Leadership Team, including a full scientific and clinical staff, which is headquartered in Norwalk, Conn | Commercial Services |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
EQRx International, Inc.
EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Health Technology |
| FasterCures |
- Stock Market
- Insiders
- Kathryn E. Giusti
